Avesthagen revives public issue plans to raise funds
September 8th, 2009 - 10:18 pm ICT by IANSBangalore, Sep 8 (IANS) Leading biotechnology firm Avesthagen plans to raise about Rs.6-7 billion (Rs.600-700 crore) through an initial public issue (IPO) for rolling out about 40 products which are still in development stage, a top company official said Tuesday.
“We will go for a public issue next year when our biosimilars (bio-pharmaceutical products) are ready to hit the market. We see a global turnaround taking place by mid-2010 from an investment perspective,” Avesthagen founder-chairman and managing director Villoo Morawala-Patell said in a statement here.
The nine-year-old company’s valuation for the fixing the issue price will be based on its patents and product portfolios.
It holds 560 patents and has projected a sales turnover of Rs.1 billion (Rs.100 crore) for this fiscal (2009-10).
As chief promoter, Morawala-Patell has 32 percent share in the company’s equity, with private equity investors such as ICICI Ventures, Fidelity and New York Life Investment Management India Fund holding 28 percent and the rest (40 percent) with minority investors, including high net-worth individuals through private placement.
The company withdrew its draft prospectus for the IPO in November 2008 after the global financial crisis rocked the investment climate the world over.
“Our four strategic business units will be run as independent profit centres with dedicated teams. We also plan to monetise products, which are in the pipeline, by launching them in the market. With an integrated systems biology platform, Avesthagen focuses on achieving convergence of food, pharma and population genetics for predictive, preventive and personalised healthcare.
- Avesthagen forms joint venture with Chilean firm - Mar 20, 2009
- New tax saving scheme for equity investment, STT cut proposed - Mar 16, 2012
- Promoters skip IPO route in unfavourable market - Jul 01, 2011
- Biocon ties up with Pfizer to market biosimilars - Oct 18, 2010
- Companies deferring public issue in bearish markets - Nov 28, 2011
- Coal India to decide on anchor investor in two-three days - Aug 13, 2010
- Tamil Nadu firm to cultivate cotton, soya in Ethiopia - Jul 26, 2011
- Tecpro Systems allots shares to eight anchor investors - Sep 23, 2010
- L&T; planning private equity fund after IPO - Jul 25, 2011
- Government okays FDI proposals worth Rs.4,341 crore - Jan 13, 2011
- 16 FDI proposals worth over $20 million accepted - Jun 07, 2011
- Tube Investments logs 37 percent net profit growth - Apr 30, 2012
- India's largest initial public offering opens Monday - Oct 17, 2010
- 11 IPOs as companies cash in on bull run - Sep 20, 2010
- India clears 20 FDI proposals worth $373 million - Jan 10, 2012
Tags: avesthagen, biotechnology firm, chief promoter, draft prospectus, founder chairman, global financial crisis, high net worth individuals, india fund, investment climate, investment perspective, life investment, management india, minority investors, patell, population genetics, private equity investors, product portfolios, profit centres, sales turnover, systems biology